About the Seminar

As gene therapies move toward commercialization, a robust, scalable, and affordable manufacturing process is critical to ensure these novel therapies reach the patient and that a pipeline of clinical assets can be rapidly developed. Join us to hear how Danaher Life Science companies Pall Corporation, Cytiva, and Precision NanoSystems (PNI) have successful technologies that help the industry with potential solutions.